MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2023 International Congress

    Weighing tremor reduction and side effects: Impact of efficacy and safety outcomes on patient satisfaction at 6 months in MR-guided focused ultrasound thalamotomy for tremor treatment

    F. Buechele, S. Mahendran, M. Uhl, C. Freudinger, A. Maric, M. Oertel, C. Baumann, L. Stieglitz (Zurich, Switzerland)

    Objective: To relate efficacy and safety outcomes to patient satisfaction at 6 months after MR-guided focused ultrasound (MRgFUS) thalamotomy in the ventral intermediate nucleus (VIM)…
  • 2023 International Congress

    A single centre retrospective study of dual target deep brain stimulation for clinically complex essential and dystonic tremor – a 5-year follow up

    H. Shepherd, R. Heartshorne, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

    Objective: Measure efficacy of dual target deep brain stimulation in pharmaco-refractory tremors. Background: Tremor is characterised by involuntary rhythmic movement present in one or more…
  • 2023 International Congress

    Axial tremor response to tractography-defined focused ultrasound thalamotomy for essential tremor: a prospective study

    C. Ribacoba Díaz, A. Fernández Revuelta, M. Yus Fuertes, C. Pérez García, E. López Valdés, R. García Ramos (Madrid, Spain)

    Objective: To analyse the effects of unilateral magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy defined by 4-tract tractography on axial tremor at 6 months in patients…
  • 2023 International Congress

    Istradefylline effect on Parkinson’s Disease Tremor, Motor symptoms and non-Motor symptoms.

    K. Chandrakumar, B. Wilmarth, B. Nagle, G. Di Maria, O. Gonul, L. Lovelace, E. Waldon, K. Getchell, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: Istradefylline is FDA approved for use in patients with PD treated with carbidopa-levodopa to reduce off time. GUH Movement Disorder Group has observed that…
  • 2023 International Congress

    Neuropsychological Outcomes After Bilateral Focused Ultrasound Thalamotomy within Essential Tremor

    M. Obolsky, N. Amitrano, N. Patel, S. Sani, M. Afshari, M. Wodziak, B. Bernard, S. Anderson, D. Gonzalez (Chicago, USA)

    Objective: The objective of the study was to elucidate the neuropsychological outcomes in executive functioning for patients with essential tremor undergoing bilateral MRI guided Focused…
  • 2023 International Congress

    Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects

    J. Janssen Daalen, M. Meinders, F. Giardina, S. Mathur, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: In this study, we describe the safety and short-term effects of the first hypoxia-based treatment trial in Parkinson’s disease by deploying a personalized multiple…
  • 2023 International Congress

    Comparing Change in Motor and ADL Rating Scales after DBS in Parkinson’s disease, Dystonia and Tremor

    Y. Wiggerts, E. Markidis, A. Weide, M. Bot, V. Odekerken, P. Munckhof, J. Dijk, Y. Namavar, R. Schuurman, R. Bie, M. Beudel (Amsterdam, Netherlands)

    Objective: To assess the relationship between deep brain stimulation (DBS)-induced improvements on motor symptoms and activities of daily living (ADL) in a single-center cohort of…
  • 2023 International Congress

    Botulinum toxin-A in head and upper extremities tremor. A hand-made option

    H. Shehata, M. Shehata, M. Basheer, A. Elmazny, N. Shalaby (Cairo, Egypt)

    Objective: This was a 24-week open-label study to assess the role of BoNT-A injections for various types of hand and head tremor Background: Focal treatment…
  • 2023 International Congress

    A randomised, double blind, placebo controlled, crossover trial of incobotulinum toxin A treatment for upper limb tremor

    S. Nagaratnam, D. Wilson, H. Morales Briceno, V. Fung (Westmead, Australia)

    Objective: To assess the clinical and functional outcomes in patients with upper limb tremor with incobotulinum toxin A injections. Background: Upper limb tremor can be…
  • 2023 International Congress

    Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation

    R. Kota, K. Garg, M. Singh, R. Rajan (NEW DELHI, India)

    Objective: The association of sinking flap syndrome with Parkinsonian tremors is very rare Background: The association of sinking flap syndrome with Parkinsonian tremors is very…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley